A Single Autologous Stem Cell Transplant (Asct) Followed By Two Years Of Post-Transplant Therapy In Recently Diagnosed Elderly Multiple Myeloma (Mm) Patients. Safety And Response Results From The Prospective Phase Ii Trial (Nct01849783)
BLOOD（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要